期刊文献+
共找到11篇文章
< 1 >
每页显示 20 50 100
Improved anti-tumor efficacy and pharmacokinetics of bufalin via PEGylated liposomes 被引量:4
1
作者 Jia-ni YUAN Xuan-xuan ZHOU +4 位作者 Wei CAO Lin-lin BI Yi-fang ZHANG Qian YANG Si-wang WANG 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2017年第10期978-979,共2页
OBJECTIVE To determine the characterization,anti-tumor efficacy and pharmacokinetics of bufalin-loaded PEGylated liposomes compared with bufalin entity.METHODS Bufalin-loaded PEGylated liposomes and bufalin-loaded lip... OBJECTIVE To determine the characterization,anti-tumor efficacy and pharmacokinetics of bufalin-loaded PEGylated liposomes compared with bufalin entity.METHODS Bufalin-loaded PEGylated liposomes and bufalin-loaded liposomes were prepared reproducibly with homogeneous particle size by the combination of thin film evaporation method and high pressure homogenization method.The particle size and zeta potential of the liposomes were determined by dynamic light scattering technique.The direct imaging of morphology of liposomes was charactered by transmission electron microscope.The content of bufalin in liposomes was analysed by HPLC method.The entrapment efficiency and the particle size was applied to assess the stability profile,after storage at 4℃ on day 0,7,15,30 and 90.The in-vitro release behaviours of bufalin from liposomes were conducted using dialysis bag technique at 37℃.In-vitro cytotoxicity studies were carried out using MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide]assay on several kinds of tumor cel lines including SW620,PC-3,MDA-MB-231,A549,U251,U87 and HepG2.In-vivo pharmacokinetic study of bufalin liposomes was evaluated by HPLC method.RESULTS Their mean particle sizes were 127.6 nm and 155.0 nm,mean zeta potentials were 2.24 m V and-18.5 m V,entrapment efficiencies were 76.31%and 78.40%,respectively.In-vitro release profile revealed that the release of bufalin in bufalin-loaded PEGylated liposomes was slower than that of bufalin-loaded liposomes.The cytotoxicity of blank liposomes has been found within acceptable range,whereas bufalin-loaded PEGylated liposomes showed enhanced cytotoxicity to U251 cells compared with bufalin entity.In-vivo pharmacokinetics indicated that bufalinloaded PEGylated liposomes could extend eliminate half-life time of bufalin in plasma in rats.CONCLUSION The results suggested that bufalin-loaded PEGylated liposomes improved the solubility and increased the drug concentration in plasma. 展开更多
关键词 BUFALIN PEGylated liposome high pressure homogenization PHARMACOKINETICS
在线阅读 下载PDF
Experimental studies on gene transfer into hematopoietic stem cells mediated by liposome and the influence of expansion on gene expression
2
作者 Hua-Zhong Lu, Ping Zou, Chong-Yu Li, Zhi-Fu Xiang Hematology Institute, Tongji Medical University, Wuhan430022 《中国实验血液学杂志》 CAS CSCD 1997年第3期326-326,共1页
Liposomes have several advantages over viral vectorsfor gene delivery both in vitro and in vivo. However,few data are available concerning gene transfer intohematopoietic stem cells. In order to explore theefficiency ... Liposomes have several advantages over viral vectorsfor gene delivery both in vitro and in vivo. However,few data are available concerning gene transfer intohematopoietic stem cells. In order to explore theefficiency and the stability of expression of gene transferinto hematopoietic stem cells, we have transduced twomarker genes (Neo^R and Lac Z) co-transfer into humanbone marrow CD34^+ hematopoietic stem cells 展开更多
关键词 HEMATOPOIETIC liposome concerning COLONY expanded MARKER remarkably stain
在线阅读 下载PDF
The efficacy of CDKN2 gene mediated by a stearylamine liposome vector on the NSCLC cell proliferation
3
作者 Gui-Lan Wen, Jiang-Qi Li, Xi-Guang Fan, Wei-Hua RaoThe Second Affiliated Hospital, Jiang Xi Medical College, Nanchang 330006 《中国实验血液学杂志》 CAS CSCD 1997年第3期336-336,共1页
The CDKN2 (MTS1/P16<sup>INK4A</sup>) is believed as atumor suppressor gene. It maps in the human’schromosome gp21. It encodes a p16<sup>INK4A</sup> protein thatis an inhibitor of cyclin-depend... The CDKN2 (MTS1/P16<sup>INK4A</sup>) is believed as atumor suppressor gene. It maps in the human’schromosome gp21. It encodes a p16<sup>INK4A</sup> protein thatis an inhibitor of cyclin-dependent kinase 4. CDKN2gene’s homozygous deletion is common in many tumorderived cell lines. Purpose: We examine 展开更多
关键词 liposome SUPPRESSOR DELETION CANDIDATE inhibiting treating clinically
在线阅读 下载PDF
Liposome as vaccine adjuvant and delivery system
4
作者 GUO Xiu-Xia YANG Qian +1 位作者 YU Hong-Tao SHENG Jun 《中国免疫学杂志》 CAS CSCD 北大核心 2006年第6期585-591,共7页
关键词 CPGODN liposome as vaccine adjuvant and delivery system ORAL CTLS
在线阅读 下载PDF
Preparation and Characterization of Danofloxacin Mmesylate Liposomes
5
作者 ZHANG Dexian LI Jichang 《Journal of Northeast Agricultural University(English Edition)》 CAS 2011年第3期33-38,共6页
Five different methods were tested and compared to prepare danofloxacin mesylate liposomes, the ammonium sulfate gradient method with freeze-thawing steps was validated as the best one; the optimal preparation conditi... Five different methods were tested and compared to prepare danofloxacin mesylate liposomes, the ammonium sulfate gradient method with freeze-thawing steps was validated as the best one; the optimal preparation condition confirmed by orthogonal experiment was as follows: EPC-CH ratio was 3 : 2 and 2.6% SA was added to gain the positive electricity; drug-lipoid was 2 : 5, the concentration of ammonium sulfate was 250 mmol·L-1, water-oil ratio was 1:5, and they were incubated at 35℃ for 15 min. The prepared liposome products were ivory white semitransparent suspension, the electron microscope appearance was intact and globular or globular-like vesicles with uniformed distribution; the particle size was centralized from 3 to 7 gm, zeta-electric potential valued+ (15.92+1.49) mV, pH valued 6.02~0.09; HPLC method was established in quantitative analyses of danofloxacin and reverse dialysis with RP-HPLC method was validated for determination of entrapment efficiency. The entrapment efficiency results were all above 90%. They were stored at 4℃ with satisfied stability. Six months later, the appearance, characters and entrapment efficiency were almost with no change 展开更多
关键词 danofloxacin mesylate liposome PREPARATION characterization determination
在线阅读 下载PDF
Liposome控告Vestar
6
作者 王璋瑜 《生物技术通报》 CAS CSCD 1992年第12期20-20,共1页
新泽西州的Liposome公司指控加州的Vestar公司有意侵犯其有关脂质体胶状扩散的专利。Liposome宣称,Vestar的产品AmBisome是盗用其技术而开发出来的。现在Liposome要求Vestar割让一部分利润。据称,Vestar早就知道Liposome有这么一項专利... 新泽西州的Liposome公司指控加州的Vestar公司有意侵犯其有关脂质体胶状扩散的专利。Liposome宣称,Vestar的产品AmBisome是盗用其技术而开发出来的。现在Liposome要求Vestar割让一部分利润。据称,Vestar早就知道Liposome有这么一項专利,但从来不认为该专利适用于其生产过程。认为该产品来自“自己的专利技术”。AmBisome是一种静脉用amphotericin B脂质体制剂。 展开更多
关键词 脂质体制剂 真菌感染 胶状 liposome Vestar 生产过程 抗感染药
在线阅读 下载PDF
几家 Liposome 公司将合并
7
作者 朱遐 《生物技术通报》 CAS CSCD 1989年第10期29-30,共2页
Liposome Co.和 Liposome Technology Inc.计划合并成一个公司,这是上述两个公立生物技术公司在不到一年中第二次公布合并计划。新公司 Liposome Companies Inc.的总部将设在新泽西州的普林斯顿,但仍保留在加利福尼亚州门罗公园处的业... Liposome Co.和 Liposome Technology Inc.计划合并成一个公司,这是上述两个公立生物技术公司在不到一年中第二次公布合并计划。新公司 Liposome Companies Inc.的总部将设在新泽西州的普林斯顿,但仍保留在加利福尼亚州门罗公园处的业务。经股东批准的计划中的合并,具有金融和市场方面的意义:两家公司都正在研制脂类和脂质体药物递送系统且正在走俏。在门罗公园的 Liposome Technology(LTI)报道。 展开更多
关键词 门罗 生物技术公司 普林斯 加利福尼亚州 liposome 脂类 中第 支气管扩张药 呼吸系统疾病 抗生素类
在线阅读 下载PDF
Platinum Nanoparticle-based Collision Electrochemistry for Rapid Detection of Breast Cancer MCF-7 Cells 被引量:1
8
作者 Fu-Xing Qin Ming-Ke Li +4 位作者 Hui-Long Zhou Wei Wen Xiu-Hua Zhang Sheng-Fu Wang Zhen Wu 《电化学(中英文)》 CAS 北大核心 2024年第10期19-27,共9页
Cancer metastasis is the leading cause of death in cancer patients worldwide and one of the major challenges in treating cancer.Circulating tumor cells(CTCs)play a pivotal role in cancer metastasis.However,the content... Cancer metastasis is the leading cause of death in cancer patients worldwide and one of the major challenges in treating cancer.Circulating tumor cells(CTCs)play a pivotal role in cancer metastasis.However,the content of CTCs in peripheral blood is minimal,so the detection of CTCs in real samples is extremely challenging.Therefore,efficient enrichment and early detection of CTCs are essential to achieve timely diagnosis of diseases.In this work,we constructed an innovative and sensitive single-nanoparticle collision electrochemistry(SNCE)biosensor for the detection of MCF-7 cells(human breast cancer cells)by immunomagnetic separation technique and liposome signal amplification strategy.Liposomes embedded with platinum nanoparticles(Pt NPs)were used as signal probes,and homemade gold ultramicroelectrodes(Au UME)were used as the working electrodes.The effective collision between Pt NPs and UME would produce distinguishable step-type current.MCF-7 cells were accurately quantified according to the relationship between cell concentration and collision frequency(the number of step-type currents generated per unit time),realizing highly sensitive and specific detection of MCF-7 cells.The SNCE biosensor has a linear range of 10 cells·mL^(-1)to 10^(5) cells·mL^(-1)with a detection limit as low as 5 cells·mL^(-1).In addition,the successful detection of MCF-7 cells in complex samples showed that the SNCE biosensors have great potential for patient sample detection. 展开更多
关键词 Circulating tumor cells Single-nanoparticle collision electrochemistry Immunomagnetic separation liposome Platinum nanoparticles
在线阅读 下载PDF
Nonviral gene transfer with Mposome and protein
9
作者 J.H.Zhu L.Zhang R.Reszka 《中国实验血液学杂志》 CAS CSCD 1997年第3期336-336,共1页
The development of improved gene transfermethods is a prerequisite for gene therapy to realizeits full potentials. One approach is the design ofplasmid-based delivery system that also termed "self-assembling comp... The development of improved gene transfermethods is a prerequisite for gene therapy to realizeits full potentials. One approach is the design ofplasmid-based delivery system that also termed "self-assembling complexes" such as cationic liposome-DNAcomplex (lipoplex) and protein-DNA complex.Unlike viral vectors, liposome-DNA complexes arenoninfectious, nonimmunogenic and exhibit low 展开更多
关键词 PREREQUISITE liposome assembling complexes CATIONIC DNA TRANSFECTION LUCIFERASE augmentation OVERCOME
在线阅读 下载PDF
Magnetic iron oxide nanoparticles carrying PTEN gene to reverse cisplatin-resistance of A549/CDDP cell lines
10
作者 闵凌峰 何玲玲 +2 位作者 陈琼 俞巧 谢明萱 《Journal of Central South University》 SCIE EI CAS 2012年第2期331-339,共9页
To evaluate the feasibility of using magnetic iron oxide nanoparticle as wild PTEN gene carrier for transfection in vitro to reverse cisplatin-resistance of A549/CDDP cells, A549/CDDP cells were transfected with the w... To evaluate the feasibility of using magnetic iron oxide nanoparticle as wild PTEN gene carrier for transfection in vitro to reverse cisplatin-resistance of A549/CDDP cells, A549/CDDP cells were transfected with the wild PTEN gene expression plasmid (pGFP-PTEN) by magnetic iron nanoparticle and lipo2000. The transfection efficiency was detected by fluorescence microscope and flow cytometer. The expression levels of PTEN mRNA and protein were detected by reverse transcription polymerase chain reaction (RT-PCR) and immunocytochemistry analysis. The effect of PTEN transfection on cell cycle enhances the sensitivity of A549/CDDP to cisplatin and nanoparticle-mediated transfection has a higher efficiency than that of the liposome-mediated group. The apoptosis level was up-regulated in PTEN transfection group. The magnetic iron oxide nanoparticle could be used as one of the ideal gene carriers for PTEN gene delivery in vitro. PTEN can be an effective target for reversing cisplatin-resistance in lung cancer. 展开更多
关键词 magnetic iron oxide nanoparticle liposome transfection lung cancer PTEN cisplatin-resistance
在线阅读 下载PDF
Construction of plasmid containing human blood- clotting factor Ⅷ and observation its expression in Cos-7 cells
11
作者 Jian Lu, Zhi-Long Jiang, Shi-Shu Chen Department of Biochemistry and Laboratory of Molecular Biology , Center of Human Gene Therapy, Shanghai Second Medical University, Shanghai 200025 《中国实验血液学杂志》 CAS CSCD 1997年第3期325-325,共1页
Factor Ⅷ deficiency or hemophilia A is X-linkedgenetic disorder in human. General treatment of severehemophilia A consists of adiministration of plasma-derived or recombinant clotting factor concentrates. Ithas cause... Factor Ⅷ deficiency or hemophilia A is X-linkedgenetic disorder in human. General treatment of severehemophilia A consists of adiministration of plasma-derived or recombinant clotting factor concentrates. Ithas caused a series of problems, i. e. viral infection andcost too much to use rF Ⅷ. Nowadays, people havedeveloped the retroviral vector and the adcnoviral 展开更多
关键词 PLASMID ADENOVIRUS EUKARYOTIC transferring EXPRESSING liposomes CATIONIC Nature
在线阅读 下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部